Use of chemotherapy at the end of life among Taiwanese cancer decedents, 20012006

Acta Oncologica

Volumn 51, Issue 4, 2012, Pages 505-511

  Liu, Tsang Wu ^a   Chang, Wen Cheng ^b   Wang, Hung Ming ^b   Chen, Jen Shi ^b   Koong, Shin Lan ^c   Hsiao, Shu Chun ^c   Tang, Siew Tzuh ^d  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c DEPARTMENT OF HEALTH   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BILE DUCT CANCER; BRAIN CANCER; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; COHORT ANALYSIS; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; ESOPHAGUS CANCER; FEMALE; HEAD AND NECK CANCER; HEALTH CARE SYSTEM; HOSPICE CARE; HUMAN; LIVER CELL CARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MARRIAGE; METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREAS CANCER; PHYSICIAN; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; RISK FACTOR; STOMACH CANCER; TAIWAN; TEACHING HOSPITAL; TERMINAL CARE;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COMORBIDITY; DELIVERY OF HEALTH CARE; FEMALE; HEALTH SERVICES; HUMANS; MALE; NEOPLASMS; PHYSICIANS, PRIMARY CARE; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; TAIWAN; TERMINAL CARE;

EID: 84859781322     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2011.653440     Document Type: Article

References (35)

1. Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 2004;22:315-21.
2. Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ. Aggressiveness of cancer care near the end of life: Is it a quality-of-care issue? J Clin Oncol 2008;26:3860-6.
3. Setoguchi S, Earle CC, Glynn R, Stedman M, Polinski JM, Corcoran CP, et al. Comparison of prospective and retrospective indicators of the quality of end-of-life cancer care. J Clin Oncol 2008;26:5671-8.
4. Sharma G, Freeman J, Zhang D, Goodwin JS. Trends in end-of-life ICU use among older adults with advanced lung cancer. Chest 2008;133:72-8.
5. Keam B, Oh DY, Lee SH, Kim DW, Kim MR, Im SA, et al. Aggressiveness of cancer-care near the end-of-life in Korea. Jpn J Clin Oncol 2008;38:381-6.
6. Goncalves JF, Goyanes C. Use of chemotherapy at the end of life in a Portuguese oncology center. Support Care Cancer 2008;16:321-7.
7. Temel JS, McCannon J, Greer JA, Jackson VA, Ostler P, Pirl WF, et al. Aggressiveness of care in a prospective cohort of patients with advanced NSCLC. Cancer 2008;113:826-33.
8. Earle CC, Park ER, Lai B, Weeks JC, Ayanian JZ, Block S. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol 2003; 21:1133-8.
9. Keating NL, Ladrum MB, Lamont EB, Earle CC, Bozeman SR, McNeil BJ. End-of-life care for older cancer patients in the veterans health administration versus the private sector. Cancer 2010;116:3732-9.
10. Barbera L, Paszat L, Qiu F. End-of-life care in lung cancer patients in Ontario: Aggressiveness of care in the population and a description of hospital admissions. J Pain Symptom Manage 2008;35:267-74.
11. Braga S, Miranda A, Fonseca R, Passos-Coelho JL, Fernandes A, Costa JD, et al. The aggressiveness of cancer care in the last three months of life: A retrospective single centre analysis. Psycho-Oncol 2007;16:863-8.
12. Martoni AA, Tanneberger S, Mutri V. Cancer chemotherapy near the end of life: The time has come to set guidelines for its appropriate use. Tumori 2007;93:417-22.
13. Kao S, Shafi q J, Vardy J, Adams D. Use of chemotherapy at end of life in oncology patients. Ann Oncol 2009;20:1555-9.
14. Barbera L, Paszat L, Chartier C. Indicators of poor quality endof- life cancer care in Ontario. J Palliat Care 2006;22:12-7.
15. Emanuel EJ, Young-Xu Y, Levinsky NG, Gazelle G, Saynina O, Ash AS. Chemotherapy use among Medicare benefi ciaries at the end of life. Ann Intern Med 2003;138:639-44.
16. Bureau of National Health Insurance. NHI profi le. Available from: http://www.nhi.gov.tw/webdata/AttachFiles/ Attach-12365-2-96 -ch.pdf. (in Chinese) October 13, 2011.
17. Bureau of Health Promotion. Cancer registry annual report, 2006 Taiwan. Available from: http://crs.cph.ntu.edu.tw/uploadimages/ Y95-ALL.pdf. (in Chinese) October 13, 2011.
18. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Clin Epidemiol 1992;45:613-9.
19. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40: 373-83.
20. Burton P, Gurrin L, Sly P. Extending the simple linear regression model to account for correlated responses: An introduction to generalized estimating equations and multilevel mixed modeling. Stat Med 1998;17:1261-91.
21. Grunfeld E, Lethbridge L, Dewar R, Lawson B, Paszat LF, Johnston G, et al. Towards using administrative databases to measure population-based indicators of quality end-of-life care: Testing the methodology. Palliat Med 2006;20:769-77.
22. Sato K, Miyashita M, Morita T, Sanjo M, Shima Y, Uchitomi Y. Quality of end-of-life treatment for cancer patients in general wards and the palliative care unit at a regional cancer center in Japan: A retrospective chart review. Support Care Cancer 2008;16:113-22.
23. Yun YH, Kwak M, Park SM, Kim S, Choi JS, Lim HY, et al. Chemotherapy use and associated factors among cancer patients near the end of life. Oncology 2007;72:164-71.
24. Asola R, Huhtala H, Holli K. Intensity of diagnostic and treatment activities during the end of life of patients with advanced breast cancer. Breast Cancer Res Treat 2006;100: 77-82.
25. Bookwala J, Coppola KM, Fagerlin A, Ditto PH, Danks JH, Smucker WD. Gender differences in older adults ' preferences for life-sustaining medical treatments and end-of-life values. Death Studies 2001;25:127-49.
26. Carr D, Khodyakov D. End-of-life health care planning among young-old adults: An assessment of psychosocial infl uences. J Gerontol: Soc Sci 2007;62B:S135 - 41.
27. Shugarman LR, Decker SL, Bercovitz A. Demographic and social characteristics and spending at the end of life. J Pain Symptom Manage 2009;38:15-26.
28. Iwashyna TJ, Christakis NA. Marriage, widowhood, and health-care use. Soc Sci Med 2003;57:2137-47.
29. Jatoi A, Novotny P, Cassivi S, Clark MM, Midthun D, Patten CA, et al. Does marital status impact survival and quality of life in patients with non-small cell lung cancer? Observations from the Mayo Clinic Lung Cancer Cohort. Oncologist 2007;12:1456-63.
30. Wachterman MW, Sommers BD. The impact of gender and marital status on end-of-life care: Evidence from the National Mortality Follow-Back Survey. J Palliat Med 2006;9:343-52.
31. Jennens RR, Boer RD, Irving L, Ball DL, Rosenthal MA. Differences of opinion: A survey of knowledge and bias among clinicians regarding the role of chemotherapy in metastatic non-small cell lung cancer. Chest 2004;126:1985-93.
32. Matsuyama R, Reddy S, Smith TJ. Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol 2008;24:3490-6.
33. Grunfeld E, Urquhart R, Mykhalovskiy E, Folkes A, Johnston G, Burge FI, et al. Toward population-based indicators of quality end-of-life care: Testing stakeholder agreement. Cancer 2008;112:2301-8.
34. Tang ST, Liu TW, Lai MS, Liu LN, Chen CH. Concordance of preferences for end-of-life care between terminally-ill cancer patients and their family caregivers in Taiwan. J Pain Symptom Manage 2005;30:510-8.
35. Weeks JC, Cook EF, O'Day SJ, Peterson LM, Wenger N, Reding D, et al. Relationship between cancer patients ' predictions of prognosis and their treatment preferences. JAMA 1998;279:1709-14.